You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Parathyroid disorders

Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]

  • In development
  • Reference number: GID-TA11454
  • Expected publication date:  22 April 2026
  • Project information
  • Project documents

On this page

  1. Draft guidance
  2. Declaration of interests
  3. Invitation to participate
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6380
  5. Topic selection

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Public committee slides (PDF 794 KB)

    Published:
    31 October 2025
  • Equality impact assessment (downloadable version) (PDF 137 KB)

    Published:
    31 October 2025
  • Committee papers (PDF 5.81 MB)

    Published:
    31 October 2025
  • Draft consultation document (downloadable version) (PDF 327 KB)

    Published:
    31 October 2025
  • Draft consultation document (online commenting)

Declaration of interests

  • Register of interests (PDF 147 KB)

    Published:
    24 October 2025

Invitation to participate

  • Equality impact assessment (scoping) (PDF 102 KB)

    Published:
    24 September 2024
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 269 KB)

    Published:
    24 September 2024
  • Final stakeholder list (PDF 138 KB)

    Published:
    24 September 2024
  • Final scope (PDF 119 KB)

    Published:
    24 September 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6380

  • Draft scope post referral (PDF 161 KB)

    Published:
    15 March 2024
  • Draft matrix post referral (PDF 176 KB)

    Published:
    15 March 2024

Topic selection

  • Topic selection

Back to top